Ilona Kalaszczynska

Dr. Ilona Kalaszczynska

Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland
+1
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2002 in Genes & Development
Verified
Journal Article
Open access
PDF file
MCMaria A. Ciemerych
Maria A. Ciemerych
AKAnna M. Kenney
Anna M. Kenney
ESEwa Sicinska
Ewa Sicinska
IKIlona Kalaszczynska
Ilona Kalaszczynska
RBRoderick T. Bronson
Roderick T. Bronson
PSPiotr Sicinski
Piotr Sicinski
D-cyclins (cyclins D1, D2, and D3) are components of the core cell cycle machinery. To directly test the ability of each D-cyclin to drive development of various lineages, we generated mice expressing only cyclin D1, or only cyclin D2, or only cyclin D3. We found that these “single-cyclin” embryos develop normally until late gestation. Our analyses revealed that in single-cyclin embryos, the tissue-specific expression pattern of D-cyclins was lost. Instead, mutant embryos ubiquitously expressed the remaining D-cyclin. These findings suggest that the functions of the three D-cyclins are largely exchangeable at this stage. Later in life, single-cyclin mice displayed focused abnormalities, resulting in premature mortality. “Cyclin D1-only” mice developed severe megaloblastic anemia, “cyclin D2-only” mice presented neurological abnormalities, and “cyclin D3-only” mice lacked normal cerebella. Analyses of the affected tissues revealed that these compartments failed to sufficiently up-regulate the remaining, intact D-cyclin. In particular, we found that in cerebellar granule neuron precursors, the N-myc transcription factor communicates with the cell cycle machinery via cyclins D1 and D2, but not D3, explaining the inability of D3-only mice to up-regulate cyclin D3 in this compartment. Hence, the requirement for a particular cyclin in a given tissue is likely caused by specific transcription factors, rather than by unique properties of cyclins.

14 October 2012 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
HCHui-Zi Chen
Hui-Zi Chen
MOMadhu Ouseph
Madhu Ouseph
JLJing Li
Jing Li
TPThierry Pécot
Thierry Pécot
VCVeda Chokshi
Veda Chokshi
GLGustavo Leone
Gustavo Leone
The endocycle is a variant cell cycle consisting of successive DNA synthesis and gap phases that yield highly polyploid cells. Although essential for metazoan development, relatively little is known about its control or physiologic role in mammals. Using lineage-specific cre mice we identified two opposing arms of the E2F program, one driven by canonical transcription activation (E2F1, E2F2 and E2F3) and the other by atypical repression (E2F7 and E2F8), that converge on the regulation of endocycles in vivo. Ablation of canonical activators in the two endocycling tissues of mammals, trophoblast giant cells in the placenta and hepatocytes in the liver, augmented genome ploidy, whereas ablation of atypical repressors diminished ploidy. These two antagonistic arms coordinate the expression of a unique G2/M transcriptional program that is critical for mitosis, karyokinesis and cytokinesis. These results provide in vivo evidence for a direct role of E2F family members in regulating non-traditional cell cycles in mammals.

1 July 2009 in Cell
Verified
Journal Article
Closed access
IKIlona Kalaszczynska
Ilona Kalaszczynska
YGYan Geng
Yan Geng
TITadafumi Iino
Tadafumi Iino
SMShin-Ichi Mizuno
Shin-Ichi Mizuno
YCYoon Choi
Yoon Choi
PSPiotr Sicinski
Piotr Sicinski

15 March 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
IKIlona Kalaszczynska
Ilona Kalaszczynska
KFKatarzyna Ferdyn
Katarzyna Ferdyn
Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to collect lifesaving Wharton’s jelly derived mesenchymal stem cells (WJ-MSC). Evidences that these cells possess therapeutic properties are constantly accumulating. Collection of WJ-MSC is done at the time of delivery and it is easy and devoid of side effects associated with collection of adult stem cells from bone marrow or adipose tissue. Likewise, their rate of proliferation, immune privileged status, lack of ethical concerns, nontumorigenic properties make them ideal for both autologous and allogeneic use in regenerative medicine applications. This review provides an outline of the recent findings related to WJ-MSC therapeutic effects and possible advantage they possess over MSC from other sources. Results of first clinical trials conducted to treat immune disorders are highlighted.

9 August 2021 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
KAKarolina Archacka
Karolina Archacka
IGIwona Grabowska-Kowalik
Iwona Grabowska-Kowalik
BMBartosz Mierzejewski
Bartosz Mierzejewski
JGJoanna Graffstein
Joanna Graffstein
AGAlicja Górzyńska
Alicja Górzyńska
EBEdyta Brzóska
Edyta Brzóska
Background: The skeletal muscle reconstruction occurs thanks to unipotent stem cells, i.e., satellite cells. The satellite cells remain quiescent and localized between myofiber sarcolemma and basal lamina. They are activated in response to muscle injury, proliferate, differentiate into myoblasts, and recreate myofibers. The stem and progenitor cells support skeletal muscle regeneration, which could be disturbed by extensive damage, sarcopenia, cachexia, or genetic diseases like dystrophy. Many lines of evidence showed that the level of oxygen regulates the course of cell proliferation and differentiation. Methods: In the present study, we analyzed hypoxia impact on human and pig bone marrow-derived mesenchymal stromal cell (MSC) and mouse myoblast proliferation, differentiation, and fusion. Moreover, the influence of the transplantation of human bone marrow-derived MSCs cultured under hypoxic conditions on skeletal muscle regeneration was studied. Results: We showed that bone marrow-derived MSCs increased VEGF expression and improved myogenesis under hypoxic conditions in vitro. Transplantation of hypoxia preconditioned bone marrow-derived MSCs into injured muscles resulted in the improved cell engraftment and formation of new vessels. Conclusions: We suggested that SDF-1 and VEGF secreted by hypoxia preconditioned bone marrow-derived MSCs played an essential role in cell engraftment and angiogenesis. Importantly, hypoxia preconditioned bone marrow-derived MSCs more efficiently engrafted injured muscles; however, they did not undergo myogenic differentiation.

1 October 2013 in BioResearch Open Access
Verified
Journal Article
Open access
IKIlona Kalaszczynska
Ilona Kalaszczynska
SRSlawomir Ruminski
Slawomir Ruminski
APAnna Platek
Anna Platek
IBIgor Bissenik
Igor Bissenik
PZPiotr Zakrzewski
Piotr Zakrzewski
Małgorzata Lewandowska-SzumiełMałgorzata Lewandowska-Szumieł
Małgorzata Lewandowska-Szumieł
It is expected that use of adult multipotential mesenchymal stem cells (MSCs) for bone tissue engineering (TE) will lead to improvement of TE products. Prior to clinical application, biocompatibility of bone TE products need to be tested in vitro and in vivo. In orthopedic research, sheep are a well-accepted model due to similarities with humans and are assumed to be predictive of human outcomes. In this study we uncover differences between human and ovine bone marrow–derived MSCs (BMSCs) and adipose tissue–derived MSCs (ADSCs) in response to osteogenic media. Osteogenic differentiation of BMSCs and ADSCs was monitored by alkaline phosphatase (ALP) activity and calcium deposition. Mineralization of ovine BMSC was achieved in medium containing NaH2PO4 as a source of phosphate ions (Pi), but not in medium containing β-glycerophosphate (β-GP), which is most often used. In a detailed study we found no induction of ALP activity in ovine BMSCs and ADSCs upon osteogenic stimulation, which makes β-GP an unsuitable source of phosphate ions for ovine cells. Moreover, mineralization of human ADSCs was more efficient in osteogenic medium containing NaH2PO4. These results indicate major differences between ovine and human MSCs and suggest that standard in vitro osteogenic differentiation techniques may not be suitable for all types of cells used in cell-based therapies. Since mineralization is a widely accepted marker of the osteogenic differentiation and maturation of cells in culture, it may lead to potentially misleading results and should be taken into account at the stage of planning and interpreting preclinical observations performed in animal models. We also present a cell culture protocol for ovine ADSCs, which do not express ALP activity and do not mineralize under routine pro-osteogenic conditions in vitro. We plan to apply it in preclinical experiments of bone tissue–engineered products performed in an ovine model.